Shareholding for the Period Ended September 30, 2018
Concord Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here21-10-2018
21-10-2018
Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- NAGI REDDY SEELAM Designation :- Director17-10-2018
Appointment Of Company Secretary Cum Compliance Officer With Effect From 05.10.2018
Appointment of Company Secretary cum Compliance officer with effect from 05.10.201805-10-2018
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Concord Drugs Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here01-10-2018
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizer''s report for the AGM held on 29.09.201801-10-2018
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings for AGM held on 29.09.201829-09-2018
Outcome Of The 1/2018 Extra Ordinary General Meeting Held On 24.08.2018
Sub: Outcome of 1/2018 Extra Ordinary General Meeting held on 24.08.2018 Ref: (Scrip Code: 538965) With reference to the subject cited, this is to inform the Exchange that the 1/2018 Extra Ordinary General Meeting of Concord Drugs Limited held on Friday, 24.08.2018 commenced at 10.00 A.M. at registered office of the company at Survey No 249, Brahmanapally Village, Hayatnagar Mandal, R.R. District - 501511 Telangana and concluded at 12.00 noon....24-08-2018
Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Concord Drugs Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here24-08-2018
Proceedings Of The Extra Ordinary General Meeting Held On 24.08.2018.
Proceedings of the Extra Ordinary General meeting held on 24.08.2018.24-08-2018
Fixes Book Closure for AGM
Concord Drugs Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2018 to September 29, 2018 (both days inclusive) for the purpose of 23rd Annual General Meeting (AGM) of the Company to be held on September 29, 2018.17-08-2018